Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.46 |
| ▸ | RET | P07949 | 15/20 | 0.41 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | KIF5B | P33176 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 1/20 | 0.38 |
| ▸ | CCDC6 | Q16204 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29629385 | 0.99 | EGLN1 (0.45) | EGLN1RETJAK2KIF5BKDR | |
| SCHEMBL28435956 | 0.88 | EGLN1 (0.50) | EGLN1RETJAK2KIF5BKDR | |
| SCHEMBL28441796 | 0.85 | EGLN1 (0.44) | EGLN1RETJAK2KIF5BKDR | |
| SCHEMBL29275442 | 0.84 | EGLN1 (0.44) | EGLN1RETJAK2KIF5BKDR | |
| SCHEMBL29275444 | 0.84 | EGLN1 (0.44) | EGLN1RETJAK2KIF5BKDR | |
| SCHEMBL17966637 | 0.82 | EGLN1 (0.42) | EGLN1RETJAK2KIF5BKDR | |
| SCHEMBL21744566 | 0.82 | EGLN1 (0.45) | EGLN1RETJAK2KIF5BKDR | |
| SCHEMBL21744564 | 0.82 | EGLN1 (0.45) | EGLN1RETJAK2KIF5BKDR | |
| SCHEMBL21744559 | 0.82 | EGLN1 (0.45) | EGLN1RETJAK2KIF5BKDR | |
| SCHEMBL30175348 | 0.82 | EGLN1 (0.42) | EGLN1RETJAK2KIF5BKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478519-A | Pyrazolopyridine compound or salt thereof, and preparation method and application thereof | 上海辉启生物医药科技有限公司 | 2022-05-13 | — | — | CN | disclosed |
| WO-2022083741-A1 | PYRAZOLOPYRIDINE COMPOUND OR SALT THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海辉启生物医药科技有限公司 | 2022-04-28 | — | — | WO | disclosed |